INFLUVAC 0.5 ml susp inj ser préremp 15 µg 10 pce

7680699920044 CH-69992 J07BB02 08.08.

No images available

Details

Product number
6999202
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Missouri/11/2025 (H1N1)-pdm09: reassortant virus IVR-279 derived from A/Missouri/11/2025) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Tokyo/EIS13-175/2025-like: reassortant virus derived from B/Tokyo/EIS13-175/2025 (Victoria lineage),wild type) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2 mg, kalium 0.08 mg, residui: natrii citras dihydricus, saccharum, cetrimidum, formaldehydum, gentamicini sulfas, tylosini tartras, hydrocortisonum, polysorbatum 80, ovalbuminum.

Articles (1)

Influvac 0.5 ml, Injektionssuspension in einer Fertigspritze
Injektionssuspension
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/12/2025
Professional SmPC
Français
20/12/2025
Professional SmPC
Italien
20/12/2025

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
kalii chloridum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
calcii chloridum dihydricum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
2.0 MG Substance HBESI
kalium
0.08 MG Substance HBESI
natrii citras dihydricus
- Substance RESI
saccharum
- Substance HNIDK
cetrimidum
- Substance RESI
formaldehydum
- Substance RESI
gentamicini sulfas
- Substance RESI
tylosini tartras
- Substance RESI
hydrocortisonum
- Substance RESI
polysorbatum 80
- Substance RESI
ovalbuminum
- Substance RESI

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
69992
Drug name
Influvac, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
27/10/2025
Authorization expiration date
26/10/2030
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Influenza, ab 6 Monaten

Packaging details

Description (FR)
INFLUVAC 0.5 ml susp inj ser préremp 15 µg 10 pce
Description (DE)
INFLUVAC 0.5 ml Inj Susp Fertspr 15 µg 10 Stk
Market launch
05/05/2026
Narcotic (BTM)
No

Other packaging sizes

INFLUVAC 0.5 ml susp inj 15 µg 1 pce
1 FESP
GTIN: 7680699920013
View
INFLUVAC 0.5 ml susp inj 15 µg 10 pce
10 FESP
GTIN: 7680699920020
View
INFLUVAC 0.5 ml susp inj ser préremp 15 µg 1 pce
1 FESP
GTIN: 7680699920037
View
Buy us a coffee Explore the data